COMPANY

Emmyon, Inc.

HQ: Rochester, MN source · emmyon.com ↗ · Midwest

Our mechanistic work complements and informs our small molecule work and has allowed us to discover several fundamental molecular mechanisms of muscle atrophy. We then use those data to discover small molecules that improve muscle strength, mass and metabolism. From company website Source · Oct 13, 2026

Keywords: small molecules

Location: Rochester, MN · source · Oct 15, 2026

Profile checked Oct 10, 2026

9NIH grants

Funding and NIH signals

NIH award NIH awarded $1.02M (SBIR Phase II 5R44DK142200-02, continuation, notice Jul 23, 2026). NIH RePORTER 5R44DK142200-02 (Jul 23, 2026)
Evidence (1 event)
- Jul 23, 2026 · NIH RePORTER 5R44DK142200-02
  Organization: EMMYON, INC.; City/State: Rochester, MN; Project number: 5R44DK142200-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-07-23; FY total cost (award amount): 1021719; Administering IC: National Institute of Diabetes and Digestive and Kidney Diseases; Project title: Development of novel therapeutics for obesity and type 2 diabetes; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

Jul 23, 2026 Grant Government grant — SBIR: $1.02M (annual award, as published), announced Jul 23, 2026. Agency: NIH/NIDDK. Source: government award database. source ↗
Jul 23, 2025 Grant Government grant — SBIR: $1.02M (annual award, as published), announced Jul 23, 2025. Agency: NIH/NIDDK. Source: government award database. source ↗

Funding

Last 2 years.

Jul 23, 2026 Government grant — SBIR: $1.02M (annual award, as published), announced Jul 23, 2026. Agency: NIH/NIDDK. Source: government award database. source ↗
Jul 23, 2025 Government grant — SBIR: $1.02M (annual award, as published), announced Jul 23, 2025. Agency: NIH/NIDDK. Source: government award database. source ↗

NIH awards 9

Annual award amounts. Total $5.6M.

Mar 11, 2024 NIH award 5R44CA277853-02 FY2024: $997,245 awarded for that fiscal year; activity R44 (SBIR); PI EBERT, SCOTT MATTHEW; recipient as written: EMMYON, INC., Rochester, MN. Development of novel therapeutics for cancer c source ↗
Mar 7, 2023 NIH award 1R44CA277853-01A1 FY2023: $990,411 awarded for that fiscal year; activity R44 (SBIR); PI EBERT, SCOTT MATTHEW; recipient as written: EMMYON, INC., Rochester, MN. Development of novel therapeutics for cancer source ↗
Aug 30, 2021 NIH award 5R44AR069400-03 FY2021: $745,404 awarded for that fiscal year; activity R44 (SBIR); PI EBERT, SCOTT MATTHEW; recipient as written: EMMYON, INC., Rochester, MN. Discovery of Novel Pharmaceutical Agents for S source ↗
Sep 10, 2020 NIH award 2R44AR069400-02A1 FY2020: $745,404 awarded for that fiscal year; activity R44 (SBIR); PI EBERT, SCOTT MATTHEW; recipient as written: EMMYON, INC., Rochester, MN. Discovery of Novel Pharmaceutical Agents for source ↗
Mar 25, 2019 NIH award 5R44AG047684-03 FY2019: $746,147 awarded for that fiscal year; activity R44 (SBIR); PI EBERT, SCOTT MATTHEW; recipient as written: EMMYON, INC., Rochester, MN. Development of Novel Small Molecule Therapies source ↗
Sep 17, 2018 NIH award 2R44AG047684-02A1 FY2018: $746,147 awarded for that fiscal year; activity R44 (SBIR); PI EBERT, SCOTT MATTHEW; recipient as written: EMMYON, INC., Rochester, MN. Development of Novel Small Molecule Therapie source ↗
Apr 1, 2016 NIH award 1R43AR069400-01 FY2016: $225,000 awarded for that fiscal year; activity R43 (SBIR); PI EBERT, SCOTT MATTHEW; recipient as written: EMMYON, INC., Rochester, MN. Discovery of Novel Pharmaceutical Agents for S source ↗
Jul 3, 2014 NIH award 1R41AG047684-01 FY2014: $225,000 awarded for that fiscal year; activity R41 (STTR); PI ADAMS, CHRISTOPHER M; recipient as written: EMMYON, INC., Rochester, MN. Development of Novel Small Molecule Therapies source ↗
Jun 28, 2013 NIH award 1R43AG044898-01 FY2013: $160,002 awarded for that fiscal year; activity R43 (SBIR); PI EBERT, SCOTT MATTHEW; recipient as written: EMMYON, INC., Rochester, MN. Development of novel therapies for aging-induc source ↗